Marpai (MRAI) Competitors $1.00 0.00 (0.00%) As of 04/30/2025 03:40 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock MRAI vs. OPGN, BNR, CCM, ENZ, BRTX, MGRX, KDLY, SSY, OTRK, and BGLCShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include OpGen (OPGN), Burning Rock Biotech (BNR), Concord Medical Services (CCM), Enzo Biochem (ENZ), BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), Kindly MD (KDLY), SunLink Health Systems (SSY), Ontrak (OTRK), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry. Marpai vs. OpGen Burning Rock Biotech Concord Medical Services Enzo Biochem BioRestorative Therapies Mangoceuticals Kindly MD SunLink Health Systems Ontrak BioNexus Gene Lab Marpai (NASDAQ:MRAI) and OpGen (NASDAQ:OPGN) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability, dividends and community ranking. Which has more volatility and risk, MRAI or OPGN? Marpai has a beta of 4.75, indicating that its share price is 375% more volatile than the S&P 500. Comparatively, OpGen has a beta of -1.61, indicating that its share price is 261% less volatile than the S&P 500. Which has higher valuation and earnings, MRAI or OPGN? Marpai has higher revenue and earnings than OpGen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarpai$34.87M0.43-$28.75M-$2.07-0.48OpGen$2.67M15.57-$32.67MN/AN/A Does the media refer more to MRAI or OPGN? In the previous week, OpGen had 1 more articles in the media than Marpai. MarketBeat recorded 1 mentions for OpGen and 0 mentions for Marpai. Marpai's average media sentiment score of 0.00 equaled OpGen'saverage media sentiment score. Company Overall Sentiment Marpai Neutral OpGen Neutral Does the MarketBeat Community favor MRAI or OPGN? OpGen received 299 more outperform votes than Marpai when rated by MarketBeat users. However, 66.67% of users gave Marpai an outperform vote while only 52.08% of users gave OpGen an outperform vote. CompanyUnderperformOutperformMarpaiOutperform Votes266.67% Underperform Votes133.33% OpGenOutperform Votes30152.08% Underperform Votes27747.92% Do institutionals and insiders hold more shares of MRAI or OPGN? 49.8% of Marpai shares are held by institutional investors. Comparatively, 2.7% of OpGen shares are held by institutional investors. 61.3% of Marpai shares are held by company insiders. Comparatively, 43.8% of OpGen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is MRAI or OPGN more profitable? Marpai has a net margin of -85.70% compared to OpGen's net margin of -1,140.36%. Company Net Margins Return on Equity Return on Assets Marpai-85.70% N/A -100.23% OpGen -1,140.36%N/A -287.58% SummaryMarpai beats OpGen on 8 of the 11 factors compared between the two stocks. Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$14.90M$2.00B$7.31B$7.83BDividend YieldN/A7.12%2.58%4.22%P/E Ratio-0.3815.7330.7518.48Price / Sales0.433.75172.23103.91Price / CashN/A9.3231.5134.62Price / Book-0.583.995.034.25Net Income-$28.75M$87.49M$195.49M$248.23M7 Day Performance4.17%0.36%6.23%3.29%1 Month PerformanceN/A-4.81%2.37%2.42%1 Year Performance-50.74%-26.97%12.73%5.54% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpaiN/A$1.00flatN/A-50.7%$14.90M$34.87M-0.38150Upcoming EarningsOPGNOpGenN/A$4.45+7.2%N/A+23.6%$37.18M$2.67M0.00100Gap DownHigh Trading VolumeBNRBurning Rock Biotech1.8589 of 5 stars$2.98+3.5%N/A-61.3%$30.53M$515.82M-0.991,390Short Interest ↓Positive NewsGap UpCCMConcord Medical Services0.5879 of 5 stars$4.27+0.2%N/A-4.0%$18.54M$471.70M0.00970Short Interest ↑ENZEnzo Biochem0.5442 of 5 stars$0.33-14.8%N/A-69.0%$17.03M$29.09M0.00520Gap DownHigh Trading VolumeBRTXBioRestorative Therapies3.868 of 5 stars$1.70-0.9%$18.00+961.9%+23.9%$12.73M$401,000.00-1.117Short Interest ↓MGRXMangoceuticals0.9072 of 5 stars$2.44-2.0%N/A-97.0%$12.61M$615,873.00-0.423Short Interest ↓Negative NewsKDLYKindly MD1.2804 of 5 stars$1.51+2.7%N/AN/A$9.11M$2.72M-2.29N/AShort Interest ↓Gap DownSSYSunLink Health SystemsN/A$0.91-3.0%N/A+64.6%$6.41M$31.23M6.501,376OTRKOntrak3.244 of 5 stars$1.42-1.4%$45.00+3,069.0%-64.7%$5.99M$10.85M-0.13250Short Interest ↓Positive NewsBGLCBioNexus Gene Lab0.259 of 5 stars$2.71+1.5%N/A-54.0%$4.87M$9.26M0.0030Short Interest ↑News CoverageGap Down Related Companies and Tools Related Companies OpGen Competitors Burning Rock Biotech Competitors Concord Medical Services Competitors Enzo Biochem Competitors BioRestorative Therapies Competitors Mangoceuticals Competitors Kindly MD Competitors SunLink Health Systems Competitors Ontrak Competitors BioNexus Gene Lab Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRAI) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRAI Stock Free MRAI Stock Alerts